Rivelsa

Teva Pharmaceuticals USA, Inc.🇺🇸 United States

FDA Page

Effective Date: Jun 19, 2023
Approval ID: 822e56c6-562f-4299-bf4f-eaee0c0f2b7a
Products: 1 registered
Version: 11

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RIVELSA safely and effectively. See full prescribing information for RIVELSA. RIVELSA (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1982

Quick Stats

Total Products1

Labelers2

Label Sections24

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.